02171.HK
CARsgen Therapeutics Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 12.75
+3.66%Margins
Gross margin
67.8%
EBITDA margin
-158.8%
EBIT margin
-72.4%
Net margin
-65.2%
FCF margin
-39.3%
-8.2%
Return on equity
-5.6%
Return on assets
-8.5%
Return on invested capital
0.10x
Asset turnover
-HKD 55.5M
Cash from operations
HKD 2.83
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026